Oncobiomix

San Antonio, United States Founded: 2023 • Age: 3 yrs
AI-driven insights for prostate cancer risks are delivered.
Annual revenue - Latest available
Total funding $480,000 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Oncobiomix

Oncobiomix is a company based in San Antonio (United States) founded in 2023. Oncobiomix has raised $480 thousand across 1 funding round.

  • Headquarter San Antonio, United States
  • Sectors
    Technology
  • Phone
    Locked
Operational Areas
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $480 K (USD)

    in 1 rounds

  • Latest Funding Round
    $480 K (USD), Seed

    Oct 26, 2023

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Oncobiomix

Oncobiomix has successfully raised a total of $480K through 1 strategic funding round. The most recent funding activity was a Seed round of $480 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Oncobiomix

Investments
Premium access

Investment portfolio details for Oncobiomix

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Oncobiomix

Premium access

Detailed financials for Oncobiomix

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Oncobiomix Comparisons

Oncobiomix Primary company
Description
AI-driven insights for prostate cancer risks are delivered.
Location
San Antonio, United States
Founded Year
2023
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Oncobiomix

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Oncobiomix

Premium access

Detailed competitors of Oncobiomix

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Oncobiomix

Premium access

Complete news archive for Oncobiomix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oncobiomix

Oncobiomix was founded in 2023.

Oncobiomix is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.

Michael Andre Liss is the current CEO of Oncobiomix.

Oncobiomix is a funded company, having raised a total of $480K across 1 funding round to date.

Oncobiomix was established in 2023 in San Antonio, United States. An AI-based platform is maintained to generate disease insights specifically for prostate cancer. Deep learning techniques are applied within the healthcare and biotech fields to produce real-time predictions and risk assessments for patients. Operations center on utilizing artificial intelligence to support clinical decision-making in oncology. The team is headed by CEO Michael Andre Liss.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available